Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
07/07/1998 | CA2133963C Novel mercaptoacetylamido pyridazo¬1,2|pyridazine, pyrazolo¬1,2|pyridazine, pyridazo¬1,2-a|¬1,2|diazepine and pyrazolo¬1,2-a|¬1,2|diazepine derivatives useful as inhibitors of enkephalinase and ace |
07/02/1998 | WO1998028412A1 MODIFIED HUMAN FACTOR Xa |
07/02/1998 | WO1998028300A1 Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments |
07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
07/02/1998 | WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
07/02/1998 | WO1998028269A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
07/02/1998 | WO1998028057A1 Biological fluid processing |
07/02/1998 | WO1998028009A1 Pharmaceutical compositions for freeze drying |
07/02/1998 | CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
07/02/1998 | CA2275796A1 Nitrogen containing heteroaromatics as factor xa inhibitors |
07/02/1998 | CA2271440A1 Biological fluid processing |
07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
07/01/1998 | EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor |
07/01/1998 | EP0850235A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
07/01/1998 | EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
07/01/1998 | EP0578728B1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa |
07/01/1998 | CN1186502A Compositions and methods for inhibiting thrombogenesis |
07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
07/01/1998 | CN1185967A Blood circulation promoting capsule for hemalopia |
07/01/1998 | CN1185961A Capsule for apoplexy |
07/01/1998 | CN1038937C Preparation of ergoline-8-carboxamides |
06/30/1998 | US5773612 Indol-2-one derivatives |
06/30/1998 | US5773577 Products comprising substrates capable of enzymatic cross-linking |
06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
06/30/1998 | US5773418 Fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant |
06/30/1998 | US5773417 Blood substitutes |
06/30/1998 | US5773411 Cardiovascular disorders and brain disorders and coagulants |
06/30/1998 | US5772992 For therapeutic coadministering of proteins as in hematopoietic reconstitution factors or interleukin variants |
06/25/1998 | WO1998027112A1 Cyclic peptide derivatives |
06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
06/25/1998 | WO1998026781A1 Method of treating or inhibiting neutropenia |
06/25/1998 | WO1998026776A1 Method for treating renal failure |
06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
06/25/1998 | DE19653036A1 Cyclopeptidderivate Cyclopeptide derivatives |
06/25/1998 | CA2280233A1 Cyclopeptide derivatives |
06/25/1998 | CA2273288A1 Method of treating or inhibiting neutropenia |
06/24/1998 | EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72 |
06/24/1998 | EP0849280A2 Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity |
06/24/1998 | EP0849261A1 Piperazinophenyl- and piperazinophenyloxy-carboxylic acid derivatives as well as processes and intermediates for their preparation and medicaments containing these compounds |
06/24/1998 | EP0848719A2 Inhibitors of fibrin cross-linking and/or transglutaminases |
06/24/1998 | EP0848708A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants |
06/24/1998 | EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
06/24/1998 | EP0680468B1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
06/23/1998 | US5770727 Crosslinked hemoglobin product comprising tetrameric and oligomeric hemoglobin units |
06/23/1998 | US5770699 Process for production of inhibited forms of activated blood factors |
06/23/1998 | US5770693 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
06/23/1998 | US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with |
06/23/1998 | US5770600 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors |
06/23/1998 | US5770578 Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments |
06/23/1998 | US5770575 Nipecotic acid derivatives as antithrombotic compounds |
06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
06/23/1998 | US5770425 Human tissue plasminogen activator variants |
06/23/1998 | US5770198 Anticoagulants |
06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
06/23/1998 | US5770194 Fibrin sealant compositions and methods for utilizing same |
06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
06/23/1998 | CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
06/19/1998 | CA2225091A1 Piperazinophenyl-and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising them |
06/18/1998 | WO1998025970A1 Antithrombotic peptides derived from fibronectin type ii repeats |
06/18/1998 | WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor |
06/18/1998 | WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
06/18/1998 | WO1998025641A1 MEDICAL USES OF scuPA/suPAR COMPLEX |
06/18/1998 | WO1998025611A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
06/18/1998 | WO1998025601A1 Fibrinogen receptor antagonists |
06/18/1998 | WO1998025457A1 Composition and method for preserving progenitor cells |
06/18/1998 | WO1998016523A3 Selective factor xa inhibitors |
06/18/1998 | WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd |
06/18/1998 | CA2621857A1 Peptides and compounds that bind to a receptor |
06/18/1998 | CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
06/18/1998 | CA2274477A1 Medical uses of scupa/supar complex |
06/18/1998 | CA2274142A1 Antithrombotic peptides derived from fibronectin type ii repeats |
06/18/1998 | CA2274029A1 Fibrinogen receptor antagonists |
06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
06/17/1998 | EP0689549B1 New urea derivates, their preparation and their use |
06/17/1998 | EP0636142B1 Lactam peptides having hle inhibiting activity |
06/17/1998 | EP0611376B1 Production and use of multimeric hemoglobins |
06/17/1998 | CN1184648A Health-care food oral liquor contg. donkey-hide gelatin, and its prodn. process |
06/17/1998 | CN1184636A Formulation for iron chelation process for preparing formulation |
06/17/1998 | CN1038751C Cyclopeptides |
06/17/1998 | CN1038748C Method for prepn. of sulfonamide fibrinogen receptor antagonists |
06/16/1998 | US5767239 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
06/16/1998 | US5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
06/16/1998 | US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
06/16/1998 | US5766921 Hybrid protein C |
06/16/1998 | US5766886 Modified antibody variable domains |
06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
06/11/1998 | WO1998024917A1 Thrombolytic agents with antithrombotic activity |
06/11/1998 | WO1998024908A1 Human chemokine beta-13 |
06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
06/11/1998 | WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies |
06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/11/1998 | WO1998024784A1 Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
06/11/1998 | WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity |
06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
06/11/1998 | WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
06/11/1998 | WO1998017319A3 Platelet substitutes and conjugation methods suitable for their preparation |